BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32204470)

  • 21. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Nanoscale Trans-Platinum(II)-Based Supramolecular Coordination Self-Assembly with a Distinct Anticancer Mechanism.
    He X; Yu J; Yin R; Zhang P; Xiao C; Chen X
    Adv Mater; 2024 May; 36(19):e2312488. PubMed ID: 38301714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
    Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
    PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands.
    Ravera M; Gabano E; Sardi M; Ermondi G; Caron G; McGlinchey MJ; Müller-Bunz H; Monti E; Gariboldi MB; Osella D
    J Inorg Biochem; 2011 Mar; 105(3):400-9. PubMed ID: 21421126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells.
    Boccarelli A; Giordano D; Natile G; Coluccia M
    Biochem Pharmacol; 2006 Jul; 72(3):280-92. PubMed ID: 16765322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
    Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
    Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
    Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.
    Deqnah N; Qing Yu J; Beale P; Fisher K; Huq F
    Med Chem; 2013 Jun; 9(4):539-44. PubMed ID: 23061563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination studies of platinum(II)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin.
    Garbutcheon-Singh KB; Harper BW; Myers S; Aldrich-Wright JR
    Metallomics; 2014 Jan; 6(1):126-31. PubMed ID: 24084749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligand.
    Najajreh Y; Prilutski D; Ardeli-Tzaraf Y; Perez JM; Khazanov E; Barenholz Y; Kasparkova J; Brabec V; Gibson D
    Angew Chem Int Ed Engl; 2005 May; 44(19):2885-7. PubMed ID: 15822135
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
    Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
    Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ruthenium(II) and Platinum(II) Complexes with Biologically Active Aminoflavone Ligands Exhibit In Vitro Anticancer Activity.
    Fabijańska M; Kasprzak MM; Ochocki J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
    Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
    J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro biological evaluation of platinum(II) complexes with 1-(methoxy substituted benzyl) azetidine-3,3-dicarboxylato ligands.
    Yin R; Gou S; Sun Y; Liu X
    Bioorg Med Chem; 2012 Feb; 20(4):1461-7. PubMed ID: 22264764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
    Hoffmeister BR; Hejl M; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
    Chem Biodivers; 2015 Apr; 12(4):559-74. PubMed ID: 25879501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of Newly Synthesized Platinum(IV) Complexes on Cytotoxicity and Radiosensitization of Human Tumour Cells
    Petrovic M; Popovic S; Baskic D; Todorovic M; Djurdjevic P; Ristic-Fira A; Keta O; Petkovic V; Koricanac L; Stojkovic D; Jevtic V; Trifunovic S; Todorovic D
    Anticancer Res; 2020 Sep; 40(9):5001-5013. PubMed ID: 32878788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.